← Eichor
Study identifier: NCT06413212 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Exploratory Study of Precise Therapy for Advanced Tumor Patients With Malignant Hydrothorax or Ascites by Using PTC Drug Sensitivity Testing

Condition: Lung Cancer · Breast Cancer · Gastric Cancer  ·  Sponsor: Liu Huang

PhaseN/A
Planned participants55
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

To explore the consistency between result of PTC drug screening tests and actual clinical outcome for patients with advanced malignancy.

This description comes directly from the study's public registry record.

Talk to the study team

Liu Huang  ·  63639656  ·  huangliu@tjh.tjmu.edu.cn

Always discuss trial participation with your own doctor first.

Locations (1)

Tongji HospitalWuhan, Hubei, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06413212